Index by author

February 01, 2014; Volume 81,Issue 2

  1. Aoun, Elie

    1. Managing risks of TNF inhibitors: An update for the internist
      Jennifer Hadam, MD, Elie Aoun, MD, MS, Kofi Clarke, MD and Mary Chester Wasko, MD, MSc
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 115-127; DOI: https://doi.org/10.3949/ccjm.81a.12121

      Tumor necrosis factor inhibitors pose infrequent but serious risks, including infection and malignancy.

  2. Clarke, Kofi

    1. Managing risks of TNF inhibitors: An update for the internist
      Jennifer Hadam, MD, Elie Aoun, MD, MS, Kofi Clarke, MD and Mary Chester Wasko, MD, MSc
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 115-127; DOI: https://doi.org/10.3949/ccjm.81a.12121

      Tumor necrosis factor inhibitors pose infrequent but serious risks, including infection and malignancy.

  3. Cubells, José Ramón Estela

    1. Slow-growing angiomatous lesions on the limbs
      José Ramón Estela Cubells, MD, Amparo Pérez Ferriols, MD and Víctor Alegre De Miquel, MD
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 79-80; DOI: https://doi.org/10.3949/ccjm.81a.13058

      Erythematous plaques after age 70 should raise the suspicion of classic Kaposi sarcoma.

  4. De Miquel, Víctor Alegre

    1. Slow-growing angiomatous lesions on the limbs
      José Ramón Estela Cubells, MD, Amparo Pérez Ferriols, MD and Víctor Alegre De Miquel, MD
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 79-80; DOI: https://doi.org/10.3949/ccjm.81a.13058

      Erythematous plaques after age 70 should raise the suspicion of classic Kaposi sarcoma.

  5. Fanfair, Robyn Neblett

    1. Clinical update in sexually transmitted diseases –2014
      Robyn Neblett Fanfair, MD, MPH and Kimberly A. Workowski, MD
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 91-101; DOI: https://doi.org/10.3949/ccjm.81a.13090

      With recent changes to the health care landscape, expect to encounter more patients with STDs.

  6. Ferriols, Amparo Pérez

    1. Slow-growing angiomatous lesions on the limbs
      José Ramón Estela Cubells, MD, Amparo Pérez Ferriols, MD and Víctor Alegre De Miquel, MD
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 79-80; DOI: https://doi.org/10.3949/ccjm.81a.13058

      Erythematous plaques after age 70 should raise the suspicion of classic Kaposi sarcoma.

  7. Field, Morton H.

    1. Stiff, numb hands (June 2013)
      Morton H. Field, MD
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87; DOI: https://doi.org/10.3949/ccjm.81c.02001

      Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  8. Gonzalez-saldivar, Gloria

    1. Canagliflozin (November 2013)
      René Rodríguez-Gutiérrez, MD and Gloria Gonzalez-Saldivar, MD
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87-88; DOI: https://doi.org/10.3949/ccjm.81c.02003

      Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

  9. Gupta, Kamal

    1. Anticoagulation and antiplatelet therapy in acute coronary syndromes
      Anticoagulation and antiplatelet therapy in acute coronary syndromes
      Dhssraj Singh, MD, Kamal Gupta, MD and James L. Vacek, MD, MSc
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 103-114; DOI: https://doi.org/10.3949/ccjm.81a.13016

      Antiplatelet and anticoagulant drugs prevent ischemic events but can cause bleeding. Here is how to optimize the benefit.

  10. Hadam, Jennifer

    1. Managing risks of TNF inhibitors: An update for the internist
      Jennifer Hadam, MD, Elie Aoun, MD, MS, Kofi Clarke, MD and Mary Chester Wasko, MD, MSc
      Cleveland Clinic Journal of Medicine February 2014, 81 (2) 115-127; DOI: https://doi.org/10.3949/ccjm.81a.12121

      Tumor necrosis factor inhibitors pose infrequent but serious risks, including infection and malignancy.

« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue